(Q35559539)

8 August 2017

1 reference

title

Niacin, lipids, and heart disease (English)

1 reference

Cardiology and cardiovascular medicine

8 August 2017

1 reference

1 reference

Crossref

https://api.crossref.org/works/10.1007/S11886-003-0109-X

21 March 2024

2

Moti L. Kashyap

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14558989

21 March 2024

author name string

Shaista Malik

series ordinal

1

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14558989

21 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

http://link.springer.com/content/pdf/10.1007/s11886-003-0109-x.pdf

file format

Portable Document Format

1 reference

Crossref

https://api.crossref.org/works/10.1007/S11886-003-0109-X

http://link.springer.com/article/10.1007/s11886-003-0109-x/fulltext.html

21 March 2024

1 reference

https://api.crossref.org/works/10.1007/S11886-003-0109-X

http://link.springer.com/content/pdf/10.1007/s11886-003-0109-x

21 March 2024

1 reference

Crossref

https://api.crossref.org/works/10.1007/S11886-003-0109-X

Current cardiology reports

21 March 2024

published in

1 reference

8 August 2017

5

1 reference

8 August 2017

6

1 reference

8 August 2017

470-476

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-003-0109-x

8 August 2017

0 references

cites work

The benefits of niacin in atherosclerosis

1 reference

12 December 2020

High Density Lipoprotein Metabolism in Man

1 reference

12 December 2020

Evaluating niacin in its various forms.

1 reference

12 December 2020

A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients

1 reference

12 December 2020

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

1 reference

12 December 2020

Studies on the Effect of Nicotinic Acid on Catecholamine Stimulated Lipolysis in Adipose Tissue in Vitro

1 reference

12 December 2020

Efficacy and safety of an extended-release niacin (Niaspan): a long-term study

1 reference

12 December 2020

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol

1 reference

12 December 2020

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

12 December 2020

Influence of nicotinic acid on serum cholesterol in man.

1 reference

12 December 2020

Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia

1 reference

12 December 2020

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group

1 reference

12 December 2020

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial

1 reference

12 December 2020

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

1 reference

12 December 2020

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

1 reference

12 December 2020

Homocysteine and cardiovascular disease: current evidence and future prospects

1 reference

12 December 2020

Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells

1 reference

12 December 2020

Mechanism of action of niacin on lipoprotein metabolism

1 reference

12 December 2020

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

1 reference

12 December 2020

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?

1 reference

12 December 2020

Molecular identification of high and low affinity receptors for nicotinic acid

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

12 December 2020

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

1 reference

12 December 2020

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

1 reference

12 December 2020

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

1 reference

12 December 2020

Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport

1 reference

12 December 2020

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

1 reference

12 December 2020

Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia

1 reference

12 December 2020

Differential effects of nicotinic acid in subjects with different LDL subclass patterns

1 reference

12 December 2020

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

1 reference

12 December 2020

Niacin treatment increases plasma homocyst(e)ine levels

1 reference

12 December 2020

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

12 December 2020

Cubilin, a high-density lipoprotein receptor

1 reference

12 December 2020

Identifiers

1 reference

8 August 2017

1 reference